0.2160
7667766266
x

Maple Syrup Urine Disease (MSUD)

iasparliament Logo
March 03, 2025

Why in News?

Scientists have created a new gene therapy for a debilitating genetic disorder called maple syrup urine disease (MSUD).

  • Recent Findings - The treatment can prevent recurrence of deadly symptoms in a cow calf born with the disease.
  • It prevented newborn death, normalized growth, restored coordinated expression of the affected genes and stabilized biomarkers in a calf as well as in mice.
  • Maple syrup urine disease (MSUD) – It is a rare genetic disorder characterized by deficiency of an enzyme complex (branched-chain alpha-keto acid dehydrogenase).
  • Branched-chain alpha-keto acid dehydrogenase is required to break down (metabolize) the 3 branched-chain amino acids (BCAAs) leucine, isoleucine and valine, in the body.
  • The result of this metabolic failure is that all 3 BCAAs, along with a number of their toxic byproducts, (specifically their respective organic acids), all accumulate abnormally.
  • In the classic, severe form of MSUD, plasma concentrations of the BCAAs begin to rise within a few hours of birth.
  • If untreated, symptoms begin to emerge, often within the first 24-48 hours of life.
  • Types - The classic type, intermediate type, intermittent type and possibly a thiamine-responsive type.
  • Cause - When a mutated form of the BCKDHA, BCKDHB or DBT gene is inherited from both parents.
  • Symptoms - Non-specific symptoms of increasing neurological dysfunction and include lethargy, irritability and poor feeding, soon followed by
    • Focal neurological signs such as abnormal movements, increasing spasticity and shortly thereafter, by seizures and deepening coma.
  • It is characterized by a distinctive sweet odor in the urine, reminiscent of maple syrup.
  • Risk level - If untreated, progressive brain damage is inevitable and death occurs usually within weeks or months.
  • Treatment - The disorder can be successfully managed through a specialized diet in which the three BCAAs are rigorously controlled.
  • However, even with treatment, patients of any age with MSUD remain at high risk for developing acute metabolic decompensation (metabolic crises).
    • Often triggered by infection, injury, failure to eat (fasting) or even by psychological stress.

Reference

The Hindu | Maple syrup urine disease

Login or Register to Post Comments
There are no reviews yet. Be the first one to review.

ARCHIVES

MONTH/YEARWISE ARCHIVES

sidetext
Free UPSC Interview Guidance Programme
sidetext